Cohere Health vs Humata Health

What it does

• Automates prior auth intake, review, and approval for health plans
• Auto-approves up to 90 percent of eligible auth requests
• Applies evidence-based clinical policies and physician-facing nudges
• Provider performance analytics to steer utilization management
• Payment integrity claims validation via Cohere Validate
• Delegated UM services across MSK, cardiology, imaging, sleep

Where it's strong

• Proven at national scale: over 12 million prior auth requests a year across roughly 600,000 providers, including a nationwide Humana deployment.
• High auto-approval rates (up to 90 percent) materially cut turnaround times and provider abrasion, which matters as CMS-0057 deadlines arrive.
• Well capitalized at $200M raised and expanding beyond prior auth into payment integrity, reducing single-product risk.

What buyers should weigh

• It sells to health plans, not providers; a provider organization only encounters Cohere through a payer that has adopted it.
• Much of its track record is concentrated in the Humana relationship, so plans of smaller size should ask for comparable references.
• Delegated UM and clinical policy alignment make implementations substantial projects with real compliance and integration work, not a light SaaS install.

Named customers

Humana · Geisinger Health Plan · Medical Mutual of Ohio

Integrations

What it does

• Matches payer policies to determine if prior auth is required
• Auto-gathers and bundles clinical documentation for submission
• Submits authorizations touchlessly across payer connections
• Monitors auth status and flags changes after submission
• Detects CPT mismatches before submission
• Supports gold-carding and exception-based review workflows

Where it's strong

• Founder Jeremy Friese, MD previously built and sold Verata Health, so this is a second product in the same category, not a first attempt.
• Strategic investors on the payer side (Blue Venture Fund, Optum Ventures, Highmark Ventures) give it unusual payer connectivity for a provider-facing tool.
• Real deployment scale for its age: roughly 225 hospitals and 42,000 physicians, plus CMS selecting it as a technology partner for the WISeR model.

What buyers should weigh

• Headline metrics like 96% first-pass approval and 45% fewer manual touches are vendor-reported, so validate them against your own service lines in a pilot.
• Its role as an AI clinical-review partner in the CMS WISeR model puts it on both the provider and payer sides of prior auth, which some provider organizations may see as a conflict.
• The company traces back to prior authorization assets from Olive AI, which shut down, so diligence which parts of the platform are new versus inherited.

Named customers

Texas Health Resources · Hartford HealthCare · Renown Health · Rochester Regional Health · Lee Health

Integrations